These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 11260007

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Spotlight on topical pimecrolimus in atopic dermatitis.
    Wellington K, Jarvis B.
    Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L, Cutler TP, Helander I, Nyfors B, Downes N.
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A, Baumann K, Grassberger M, Wolff K, Meingassner JG.
    Int Arch Allergy Immunol; 2006 Jan; 141(3):199-212. PubMed ID: 16926539
    [Abstract] [Full Text] [Related]

  • 33. Ascomycins in dermatology.
    Paul C, Ho VC.
    Semin Cutan Med Surg; 1998 Dec; 17(4):256-9. PubMed ID: 9859912
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner.
    Hultsch T, Müller KD, Meingassner JG, Grassberger M, Schopf RE, Knop J.
    Arch Dermatol Res; 1998 Sep; 290(9):501-7. PubMed ID: 9808344
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of Intermittent Treatment with Topical Corticosteroids and Calcineurin Inhibitors on Epidermal and Dermal Thickness Using Optical Coherence Tomography and Ultrasound.
    Aschoff R, Lang A, Koch E.
    Skin Pharmacol Physiol; 2022 Sep; 35(1):41-50. PubMed ID: 34348352
    [Abstract] [Full Text] [Related]

  • 38. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy.
    Kragballe K, Barnes L, Hamberg KJ, Hutchinson P, Murphy F, Møller S, Ruzicka T, Van De Kerkhof PC.
    Br J Dermatol; 1998 Oct; 139(4):649-54. PubMed ID: 9892908
    [Abstract] [Full Text] [Related]

  • 39. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ, Griffiths CE, Talwar HS, Finkel LJ, Rafal ES, Hamilton TA, Voorhees JJ.
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [Abstract] [Full Text] [Related]

  • 40. A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque test.
    Snape SD, Wigger-Alberti W, Goehring UM.
    Br J Dermatol; 2016 Sep; 175(3):479-86. PubMed ID: 27038440
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.